Basic information Safety Supplier Related

2,2'-dithiobis(ethylamine)

Basic information Safety Supplier Related

2,2'-dithiobis(ethylamine) Basic information

Product Name:
2,2'-dithiobis(ethylamine)
Synonyms:
  • 2,2'-dithiobis(ethylamine)
  • 2,2-DIAMINODIETHYLDISULPHIDE
  • 2,2'-Dithiobisethanamine
  • Cystinamine
  • Decarboxycystine
  • L-1591
  • Mercamine disulfide
  • 2,2'-disulfanediyldiethanamine
CAS:
51-85-4
MF:
C4H12N2S2
MW:
152.28
EINECS:
200-129-4
Mol File:
51-85-4.mol
More
Less

2,2'-dithiobis(ethylamine) Chemical Properties

Melting point:
135-136 °C
Boiling point:
106-108 °C(Press: 5 Torr)
Density 
1.090 (estimate)
refractive index 
1.5605 (estimate)
storage temp. 
Storage temp. -20°C
solubility 
Soluble in Water, DMSO, DMF, Methanol
form 
Liquid
pka
8.97±0.10(Predicted)
color 
Light yellow to brown
More
Less

2,2'-dithiobis(ethylamine) Usage And Synthesis

Description

Aminoethyl-SS-ethylamine contains two primary amine terminal groups and a cleavable disulfide bond. The terminal amines can participate in chemical reactions with carboxylic acids, activated NHS esters and other carbonyl compounds. The disulfide bond can be cleaved by Dithiothreitol (DTT) reagent.

Chemical Properties

Cystamine is an unstable liquid, and its dihydrochloride C4H12N2S2·2HCl is generally used. The latter is stable to 203-214°C and decomposes above this temperature.

Uses

Cystamine is the disulfide form of the free thiol, cysteamine. Cystamine is an orally active transglutaminase (Tgase) inhibitor. Cystamine also has inhibition activity for caspase-3 with an IC50 value of 23.6 μM. Cystamine can be used for the research of severals diseases including Huntington's disease (HD) [1][2][3].

Definition

ChEBI: An organic disulfide obtgained by oxidative dimerisation of cysteamine.

in vivo

Cystamine (oral, i.p.; 112, 225 mg/kg) reduces Tgase activity and GGEL levels, lessens the behavioral and neuropathological severity, and extends survival in R6/2 transgenic HD mice[2].

Animal Model:R6/2 transgenic HD mice[2]
Dosage:112, 225 mg/kg
Administration:Intraperitoneal or oral, daily
Result:Significantly extended survival, improved body weight and motor performance, delayed the neuropathological sequela and significantly altered the levels of Tgase activity and N(Sigma)-(gamma-L-glutamyl)-L-lysine (GGEL) levels.

IC 50

Caspase 3: 23.6 μM (IC50)

References

[1] Mathieu Lesort, et al. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem. 2003 Feb 7;278(6):3825-30. DOI:10.1074/jbc.M205812200
[2] Alpaslan Dedeoglu, et al. Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci. 2002 Oct 15;22(20):8942-50. DOI:10.1523/JNEUROSCI.22-20-08942.2002
[3] Thomas M Jeitner, et al. Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo. Biosci Rep. 2018 Sep 5;38(5):BSR20180691. DOI:10.1042/BSR20180691

2,2'-dithiobis(ethylamine)Supplier

Energy Chemical Gold
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Email
shenlinxing@macklin.cn
Puripharm Co., Ltd.
Tel
0572-2745768-1 13167223168
Email
sales@puripharm.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Email
klq@cw-bio.com